FBLG

0.705015.06%
VN

Victoria Niklas

Independent Director

Dr. Victoria Niklas, M.D., is a Director of GlycosBio Inc. She had been Chief Medical & Scientific Officer at Prolacta Bioscience Inc. since January 13, 2016. She serves as Board Member, Neonatologist at LactaLogics, Inc. Dr. Niklas has experience as a global biotechnology executive and strategy advisor in the clinical and research life sciences and pharmaceutical industries. With a clinical background as a neonatologist, her focus is to improve the care and well-being of patients through scientific research, medical discovery and new product innovation targeting unmet needs in health care. She has been an Independent Director at FibroBiologics, Inc. (Formerly, FibroBiologics LLC) since April 2021. She serves as Member of Scientific Advisory Board at Uplifting Results Labs Inc. She is the Chief Medical Officer of Oak Hill Bio since 2022. Dr. Niklas served in Global Medical Affairs and as Global Program Leader of the OHB-607 program in Rare Disease and Hematology at Takeda Pharmaceuticals. She has held positions as Chief, Division of Newborn Medicine at Nemours Children’s Hospital, Chief of Neonatology at UCLA Olive View Medical Center and Visiting Professor of Clinical Pediatrics at the David Geffen School of Medicine at UCLA. Dr. Niklas has experience as a clinician investigator and neonatologist integrating basic and translational science in diseases afflicting the newborn. Her career has focused on understanding the immune system in the susceptibility of the newborn to infection and inflammation in the body's largest mucosal surface, the intestine. She is a recognized expert in mouse models of intestinal immune T cell development and the pathogenesis of intestinal inflammation, in diseases such as necrotizing enterocolitis, a life-threatening intestinal disease of primarily premature infants. She served as Director of the Neonatal Intensive Care Unit and Newborn Services at Olive View-UCLA Medical Center and a Professor in the Department of Pediatrics at the David Geffen School of Medicine at UCLA. Throughout her career, Dr. Niklas has been a leader in research on human milk and its impact on protecting newborns from life-threatening diseases, underscoring her commitment to the healing power of breast milk. She is an expert in the role of the gut microbiome in disorders & diseases. She is board certified in Perinatal and Neonatal Medicine and holds a California medical license. In addition to being a co-author on numerous scientific and clinical publications, she has helped lead the development of patented products and has served as a board member for multiple biotech and early-stage companies in functional foods. We believe Dr. Niklas’ extensive experience and knowledge in the biotechnology sector qualifies her to serve on the Board. She completed her residency in pediatrics at Children's Hospital Los Angeles and a fellowship in perinatal and neonatal medicine at UCLA. Dr. Niklas received her MD from Harvard Medical School, her MA in Biochemistry and Molecular Biology from Harvard University and her bachelor’s in Biological Sciences from Goucher College.

Positions